The Factory Floor: Biocon, Indoco, Strides And Lupin Line Up For Inspection
As MedPharm Completes Expansion And Coripharma Concludes Packaging Deal
Biocon Pharma’s solid-dosage plant has received FDA inspection approval but its parent company was not so lucky, with one of its sites getting hit with five observations. Indoco, Strides, and Lupin were also in the regulatory spotlight while MedPharm has moved into a new, expanded facility and Coripharma has signed a packaging deal with Stada.
